Leadership
This article was written by Nicholas Mitsakos : Chairman and CEO at Arcadia Capital Group. Special thanks to Prof. Christopher Robichaud and Prof. Dana Born of Harvard’s Kennedy School of Government for their assistance in compiling this material, and their invaluable...
Biotechnology – Volatile, Risky, and Extraordinary
Biotechnology has been beaten up a lot lately and has had a very volatile and unimpressive recent history. However, biotechnology is still one of the single greatest investment opportunities available, and new and exciting factors are developing and enhancing the attractiveness of the sector
The Global Economy – The Great Moderation
Optimism is challenging when looking at the world economy. As the trade war between America and China continues, business confidence in America and elsewhere has been declining.